Apellis Pharmaceuticals is the most overbought healthcare stock as Q1 earnings roll on
Source: SeekingAlpha
2026-04-20 11:55:48 ET
More on Health Care stocks
- IHI: Pullback Creates A Buying Opportunity In High-Growth MedTech
- Routine Vaccines Okay For Now: Investment Implications Of The Court Decision
- Sector Rotation: Healthcare XLV Should Be The Next Stop
- Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research
- Notable healthcare headlines for the week: J&J, Abbott and Organon in focus
Read the full article on Seeking Alpha
For further details see:
Apellis Pharmaceuticals is the most overbought healthcare stock as Q1 earnings roll on
Arcellx Inc.
NASDAQ: ACLX
ACLX Trading
0.04% G/L:
$115.08 Last:
1,195,659 Volume:
$115.04 Open:
ACLX Latest News
March 16, 2026 07:33:01 pm
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal
ACLX Stock Data
$3,888,009,846
37,694,730
1.62%
80
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
